Sean E. Reilly, technology
investor, healthcare advocate, and chief executive officer of Lamar
Advertising Company in Baton Rouge,
Louisiana, joins the company's board of directors.
CAMBRIDGE, Mass., Jan. 11, 2017 /PRNewswire/ -- Dragonfly
Therapeutics, Inc. ("Dragonfly"), today announced the addition of
Sean E. Reilly, a longtime
technology investor, public healthcare advocate, and the Chief
Executive Officer of Lamar Advertising Company (Nasdaq: LAMR), to
its board of directors.
"Sean's career has been steeped to public service, from his
legislative career, to civic leadership in healthcare, education
and disaster recovery, to decades of work building one of the
largest North American advertising companies, employing over 3,000
people," said Bill Haney, co-founder
& CEO of Dragonfly. "As Dragonfly focuses on our mission
to revolutionize cancer treatment by inventing therapies that
harness the body's immune system, Sean's ability to understand the
market, and his demonstrated empathy for improved patient outcomes,
is incredibly valuable and complements our team of scientific
experts."
Sean E. Reilly is chief executive
officer of Lamar Advertising Company, one of the largest
advertising companies in North
America, with more than 325,000 digital and outdoor
displays, including billboards, logo signs, and transit displays
across the United States and
Canada. In addition, Mr. Reilly is an investor in numerous
startup technology companies in industries ranging from biotech to
telecommunications, and security software. Mr. Reilly has served as
a board member on a wide variety of public health and
policy-related boards including the American Diabetes Association,
Louisiana Recovery Authority, Public Affairs Research Council of
Louisiana, Duke University Sanford School of Public Policy
Board of Visitors, Volunteers of America, the Greater Baton Rouge
Hospice Foundation, and World Connect – an international Peace
Corps-partnered health & development organization, among
others. He is a graduate of Harvard
University in Cambridge,
Massachusetts, with both Bachelor of Arts (1984) magna cum
laude and Juris Doctor (1989) degrees. Mr. Reilly lives in
Baton Rouge, Louisiana, and has
been married to the former Jennifer
Eplett since 1989. They have three children, Anna Maeve, Aidan
Christopher and Rowan
Patrick.
About Dragonfly
Dragonfly Therapeutics is a discovery-stage company developing
drugs to stimulate immune responses against cancer.
Our scientific founders are major figures in cancer biology and
immunology and have launched Dragonfly to harness the power of the
immune system to provide breakthrough cancer treatments for
patients.
For more information visit: www.dragonflytx.com,
https://www.facebook.com/dragonflytherapeutics/,
https://twitter.com/dragonflytx
Contact:
Maura McCarthy
617.780.1660
maura@dragonflytx.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/dragonfly-therapeutics-adds-technology-investor-and-leading-advertising-company-ceo-to-its-board-of-directors-300389073.html
SOURCE Dragonfly Therapeutics, Inc.